PharmaCyte Biotech Balance Sheet (2011-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026	Apr2026
Receivables - Accured (Quarter)												0.14M				0.14M	0.21M	0.29M		0.24M
Assets
Current Assets
Cash & Equivalents (Quarter)	0.96M	86.94M	86.64M	85.40M	82.23M	76.96M	72.64M	68.04M	74.66M	73.43M	61.21M	50.18M	32.64M	20.84M	16.38M	15.17M	13.18M	15.41M	20.17M	18.60M
Receivables - Net (Quarter)												2.75M			3.36M
Receivables - Other (Quarter)
Receivables (Quarter)												2.75M			3.36M
Inventory (Quarter)
Prepaid Assets (Quarter)	0.55M	0.24M	0.17M	0.09M	0.03M	0.26M	0.18M	0.11M	0.09M	0.32M	0.30M	0.26M	0.24M	0.49M	0.21M	0.22M	0.24M	0.50M	0.16M	0.10M
Current Assets (Quarter)	1.51M	87.18M	86.81M	85.49M	82.26M	77.22M	72.82M	68.15M	74.75M	73.75M	61.51M	50.44M	32.88M	21.33M	16.96M	22.38M	19.11M	23.02M	20.70M	37.42M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Long-Term Investments (Quarter)	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M	1.57M		29.12M	24.86M	18.63M	22.47M	19.64M	20.75M	22.47M
Intangibles (Quarter)	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M
Goodwill & Intangibles (Quarter)	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	3.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M	1.55M
Long-Term Deferred Tax (Quarter)									4.54M	4.22M		16.24M				16.91M
Other Non-Current Assets (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	2.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Assets (Quarter)	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	5.13M	9.85M	9.46M	37.32M	33.77M	26.87M	32.79M	26.00M	32.95M	35.18M	9.33M
Assets (Quarter)	6.64M	92.31M	91.94M	90.62M	87.39M	82.35M	77.95M	73.28M	79.88M	78.88M	71.36M	59.90M	70.19M	55.10M	43.83M	55.17M	45.11M	55.98M	55.87M	46.75M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	0.39M	0.16M	0.09M	0.21M	0.56M	0.86M	0.45M	0.13M	0.72M	0.13M	0.48M	0.74M	0.55M	0.35M	0.48M	0.40M	0.47M	1.02M	1.20M	0.27M
Notes Payables (Quarter)
Dividends payables (Quarter)									0.32M	4.10M	6.28M	6.30M	6.23M	3.72M				0.04M	0.03M	0.03M
Payables (Quarter)	0.39M	0.16M	0.09M	0.21M	0.56M	0.86M	0.45M	0.13M	1.04M	4.22M	6.76M	7.03M	6.79M	4.07M	0.48M	0.40M	0.47M	1.06M	1.23M	0.30M
Accumulated Expenses (Quarter)	0.53M	0.03M	0.52M	0.50M	0.53M	0.45M	0.38M	0.46M	0.48M	1.02M	0.77M	0.74M	0.68M	0.71M	0.71M	2.54M	0.60M	0.52M	0.45M	0.52M
Other Accumulated Expenses (Quarter)			0.47M	0.38M	0.38M	0.38M	0.29M	0.29M	0.29M
Short term Debt (Quarter)
Total Current Liabilities (Quarter)	0.92M	0.19M	0.61M	0.70M	1.09M	1.31M	0.83M	0.59M	1.52M	5.24M	7.54M	7.42M	7.47M	4.78M	1.19M	2.91M	1.06M	1.58M	1.68M	0.83M
Non-Current Liabilities
Non-Current Debt (Quarter)
Preferred Stock Liabilities (Quarter)									16.75M	21.30M	17.52M	11.87M	5.33M					0.90M	0.87M	1.27M
Non-Current Deferred Tax Liability (Quarter)												1.04M				1.69M
Other Non-Current Liabilities (Quarter)									15.58M	15.57M	14.93M	10.78M	8.70M	6.87M	2.38M	0.36M	0.46M	16.15M	14.79M	10.95M
Total Non-Current Liabilities (Quarter)								0.59M	4.82M	5.24M	7.54M	9.61M	8.45M	4.78M	1.19M	2.91M	1.06M	3.27M	1.68M	0.83M
Total Liabilities (Quarter)	0.92M	0.19M	0.61M	0.70M	1.09M	1.31M	0.83M	0.59M	20.40M	20.81M	22.47M	20.39M	17.15M	11.65M	3.58M	3.28M	1.52M	19.42M	16.47M	11.77M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	5.71M	92.12M	91.33M	89.92M	86.30M	81.04M	77.12M	72.69M	39.19M	36.77M	31.37M	27.65M	47.71M	43.45M	40.25M	51.89M	43.59M	35.24M	38.11M	33.29M
Liabilities and Shareholders Equity (Quarter)	6.64M	92.31M	91.94M	90.62M	87.39M	82.35M	77.95M	73.28M	79.88M	78.88M	71.36M	59.90M	70.19M	55.10M	43.83M	55.17M	45.11M	55.98M	55.87M	46.75M
Treasury Shares (Quarter)		900.00	0.00M	0.00M	0.85M	2.08M	3.39M	4.81M	-12.89M	-12.97M	-13.15M	13.63M	13.95M	14.64M	14.77M	14.88M	14.88M	14.88M	15.27M	15.27M
Retained Earnings (Quarter)	114.17M	201.56M	201.57M	201.58M	201.59M	201.60M	202.23M	202.23M	198.64M	193.59M	189.22M	185.33M	182.72M	181.35M	181.43M	181.49M	181.55M	180.61M	183.14M	182.72M
Preferred Shares (Quarter)									20.03M

Research Tools

Datasets

Plans

Developers

PharmaCyte Biotech PMCB Balance Sheet (2011-2026)

Research Tools

Datasets

Plans

Developers

PharmaCyte Biotech PMCB Balance Sheet (2011-2026)

Create an account

Sign In

Reset Password